Breast Arterial Calcifications May Be Marker for Future Heart Disease
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 11, 2024 -- Breast arterial calcifications (BAC) identified on mammography are associated with the development of both atherosclerotic cardiovascular disease (ASCVD) events and risk factors over 18 years, according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.
Schyler Said, from Drexel University in Philadelphia, and colleagues assessed the longitudinal association between BAC and ASCVD. The analysis included 1,995 women at baseline, which decreased to 383 at 18-year follow-up.
The researchers found a significant association between BAC and freedom of an ASCVD event for participants with and without known ASCVD at baseline. In those with an ASCVD risk factor at baseline, there was a significant association between BAC and freedom of an ASCVD risk factor and a nonsignificant association in those without an ASCVD risk factor at baseline. Women with BAC were more likely to cumulatively experience ASCVD events over 18 years of follow-up (23 percent in those with BAC versus 13.9 percent in those without).
“These results suggest that the identification of BAC on routine mammography may serve as a marker for increased ASCVD risk in women over time. The presence of BAC on a mammogram should be routinely reported,” the authors wrote.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Low Rates of Isolated Locoregional Recurrence Seen in Young Women With Breast Cancer
TUESDAY, July 29, 2025 -- For women diagnosed with breast cancer at age 40 years or younger, the risk for isolated locoregional recurrence (LRR) is relatively low, according to a...
Risk-Reducing Mastectomy Cost-Effective With Breast Cancer Risk ≥35 Percent
MONDAY, July 28, 2025 -- Undergoing risk-reducing mastectomy (RRM) seems to be cost-effective for women aged 30 to 55 years with a lifetime breast cancer (BC) risk of 35 percent...
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
MONDAY, July 28, 2025 -- For individuals with type 2 diabetes (T2D) and moderate cardiovascular risk treated with metformin, the risk for major adverse cardiovascular events is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.